Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

EasyJet pre-tax profits grow in Q3, expects £25m hit to FY profits from French strikes

(Sharecast News) - Budget airline EasyJet said on Thursday that pre-tax profits had grown to £286,0m in the three months ended 30 June, up £50.0m year-on-year, but warned that profits would be impacted by recent French industrial action. EasyJet said Q3 profit growth was driven by "strong demand" for its primary airport network and benefited from the timing of Easter. Airline passenger numbers increased 2% to 25.9m, while load factor improved by 0.2ppts to 90.2%.

However, EasyJet warned of a hit to FY profits from higher fuel costs and a recent strike by French air traffic controllers at the beginning of the peak summer travel season. EasyJet expects a roughly £25.0m hit to profits for the year ending 30 September.

The FTSE 100-listed firm stated that although demand had remained strong, travellers were now taking longer to book tickets amid worsening global macroeconomic sentiment.

"The outlook for FY25 remains positive, with good profit growth expected year-on-year, albeit impacted by recent higher fuel costs and the scale of industrial action by French air traffic control," said EasyJet. "With 67% of our Airline's fourth-quarter capacity sold, the final outcome for FY25 will, as always, depend on late summer bookings and the associated yields."

Looking to Q126, EasyJet said on sale seat capacity was up roughly 5%, with 19% of the program currently sold, up 1ppt year-on-year, while its EasyJet holidays unit was currently 50% sold for Q126.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.